Article
Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-alpha production.
European journal of immunology - 1 Jul 2004
Vollstedt Sabine, O'Keeffe Meredith, Odermatt Bernhard, Beat Ryf, Glanzmann Bettina, Riesen Matthias, Shortman Ken, Suter Mark
Abstract excerpt
Treatment with the hematopoietic growth factor Flt3 ligand (FL) increases DC numbers in neonatal mice and enhances their resistance against intracellular pathogens. Flow cytometric analysis showed the presence of conventional DC (cDC) and plasmacytoid pre-DC (pDC) in neonatal spleens from untreated and FL-treated mice. CD8alpha and MHC class II expression on cDC and pDC was higher on DC from FL-treated mice than...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
